---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-106872"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-10-05T21:00:41+00:00"
generated_at: "2026-10-12T14:56:56.204806+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tessera Defense adds $5M Mandragola convertible credit line at 12%, issues 2.69M shares to lender

## Summary
- New $5,000,000 revolving line of credit from Mandragola Ltd. (Israel) signed Oct. 5, 2026; runs alongside, and does not replace, the prior $2,000,000 May 13, 2026 line.
- Advances bear 12% simple interest, mature Oct. 5, 2029, and convert at the lower of the 5-day lowest NYSE American close or $1.00 per share; 19.99% exchange cap pending stockholder approval.
- Issued 2,690,500 restricted shares to Mandragola between Sept. 29 and Oct. 2, 2026: 200,000 on conversion of a $95,020 note at $0.4751 per share.
- Remaining 2,490,500 shares came in four tranches from cashless exercises of the DFSL warrant issued to Mandragola on April 13, 2026 (60% DFSL stake acquisition).
- Company had 8,920,240 shares outstanding as of Oct. 2, 2026 after these issuances and ATM sales; no advances drawn under the new line yet.

## SEC filing metadata
- accession: 0001213900-26-106872
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-10-05T21:00:41+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026106872/0001213900-26-106872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026106872/ea0307709-8k_tessera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-106872
- JSON: https://secwatch.observer/filing/0001213900-26-106872.json
- Plain text: https://secwatch.observer/filing/0001213900-26-106872.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
